Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
Replication-incompetent adenovirus (Ad) vector and mRNA-lipid nanoparticle (LNP) constructs represent two modular vaccine platforms that have attracted substantial interest over the past two decades. Due to the COVID-19 pandemic and the rapid development of multiple successful vaccines based on thes...
Main Authors: | Provine, NM, Klenerman, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2022
|
Similar Items
-
MAIT cell activation augments adenovirus vector vaccine immunogenicity
by: Provine, N, et al.
Published: (2021) -
Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study
by: Theerada Assawasaksakul, et al.
Published: (2022-05-01) -
Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013) -
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024-12-01) -
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
by: Marta Ulaszewska, et al.
Published: (2023-01-01)